Business Development leadership for clinical stage biotechnology company focused on discovery and development of novel peptide therapeutics. Protagonist's initial focus is on first-in-class oral peptide drugs that specifically target biological pathways in diseases currently treated by antibody therapies, particularly inflammatory diseases such as Crohn's or Ulcerative Colitis.

Business Development deal lead for a public, late stage development biopharmaceutical company committed to the discovery, development, and commercialization of novel antibacterials to treat multi-drug resistant, or MDR, gram-negative infections.Develop & execute worldwide ex-US licensing strategy. Lead partnering process from target identification through term sheets and contract negotiations. Conduct evidence gap assessment, engage and manage key research to support the value proposition. Establish metrics and financial models to evaluate asset valuation and deal terms relative to strategic alternatives. Establish partnering best practices and manage diligence process in collaboration with R&D team.

Executive business leader for early stage private biopharmaceutical company focused on immuno-oncology. Primary responsibility for all aspects of finance, business development and operations.Develop financing and licensing strategies, manage fundraising and partnering efforts. Identify and engage with potential partners/investors. Structure and negotiate agreements consistent with strategic objectives.Build value propositions across multiple indications. Work with R&D leadership to develop business plans, forecasts, budgets and timelines. Provide financial oversight to research and development teams. Lead team responsible for all company operations: monthly close, financial reporting, audit, tax, treasury, equity incentive plans, HR, IT, facilities. Implement financial systems, policies and controls.Establish key vendor relationships and lead negotiation of major contractual agreements. Implement appropriate research and development infrastructure and governance. Manage corporate legal and intellectual property portfolio in partnership with external counsel.

Business Development executive for a public, late stage development drug-device combination company focused on pain therapeutics. Responsible for corporate development, licensing, strategy, alliance management and intellectual property.Sourced, negotiated and executed $250MM license agreement for commercial rights to lead program in Europe. Generated more than $50MM in non-dilutive cash to the company over first two years. Developed licensing strategy and key business metrics for successful partnering. Designed and executed multinational market research as necessary to support licensing efforts. Led development of all internal diligence materials, multi-party inbound and reverse diligence.Developed Alliance Management capabilities to integrate partner requirements into pre-commercial and development efforts. Established all governance and oversight mechanisms, led negotiation of follow-on agreements (e.g. Quality, Pharmacovigilance). Developed and managed portfolio of ~ 40 worldwide patents including both composition and methods of use for pharmaceutical and medical device aspects of the company's technology platforms.

Market Development executive for a public, development stage drug-device combination company focused on pain therapeutics. Responsible for all pre-commercialization functions including marketing, competitive intelligence, and KOL development liaison to medical affairs in addition to public relations and intellectual property.Provided commercial leadership to product development teams. Developed marketing strategy, commercial plans, market research and commercial forecasts. Established cross functional teams to build early commercial infrastructure and scale manufacturing capabilities. Negotiated all major agreements for contract manufacturing and supply chain. Developed and executed new intellectual property strategy for the company's technology platforms leading to more than a dozen patents in two years, including the first issued US patents for the company.

Financial executive and employee number three for a development stage drug-device combination company focused on pain therapeutics. Primary responsibility for all finance, accounting and operations functions including HR, IT and Facilities. Worked directly with founders to raise $120MM in equity financing, from series A venture capital through IPO. Led drafting of the S-1, serving as primary point of contact for bankers, lawyers and accountants for all financial matters. Negotiated over $30MM in venture debt agreements and credit facilities to finance capital equipment.Established corporate objectives and developed all business plans, forecasts, budgets and timelines in line with these objectives. Recruited key members of the management and development teams. Established board committees, managed board materials and communication.Established all early company infrastructure, facilities, systems, and key vendor relationships. Managed audit, tax, stock option plans and valuation. Implemented all financial systems, policies and controls.

Led strategic planning, portfolio management and decision analysis for pharmaceutical development. Provided business support to development teams and developed management recommendations across multiple therapeutic areas. Part of a small team tasked with evaluating strategic options and developed new company strategy in partnership with senior management.Supported evaluation of new technologies for in-licensing and developed business cases for out-licensing of development programs and drug delivery technology platforms.Collaborate with R&D management to build business plans and value propositions for internal development programs and emerging drug delivery technologies.

Held several roles of increasing responsibility, ultimately reporting to the CFO. Oversaw all finance, accounting and operations for a public company of 200+ employees. Managed team responsible for long-term planning and annual budget process, monthly accounting cycle, audit, tax, purchasing, payroll and stock option administration.Provided financial analysis in support of business development activities. Held primary responsibility for financial management of the company's strategic partnership with GlaxoSmithKline.Led cross-functional teams to develop the commercial systems and infrastructure necessary to launch the company’s first product. Developed and implemented a new ERP system to support company growth.

Financial planning and analysis for a venture backed company in healthcare services in the oncology space. Valuation and due diligence of small public and private companies targeted for mergers and acquisitions.

Accountant for capital leasing company. Analysis of leased asset transactions for book and tax impact, income projections, deferred taxes and cash flows. General ledger maintenance, partnership, foreign lease, and joint venture analysis and accounting.